يعرض 1 - 10 نتائج من 21 نتيجة بحث عن '"Katarina Petrakova"', وقت الاستعلام: 1.63s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy

    المؤلفون: Milos Holanek, Iveta Selingerova, Pavel Fabian, Oldrich Coufal, Ondrej Zapletal, Katarina Petrakova, Tomas Kazda, Roman Hrstka, Alexandr Poprach, Maria Zvarikova, Ondrej Bilek, Marek Svoboda

    المصدر: Diagnostics, Vol 12, Iss 7, p 1740 (2022)

    مصطلحات موضوعية: breast cancer, neoadjuvant therapy, pathological complete response, residual cancer burden, biomarkers, KI-67, Medicine (General), R5-920

    وصف الملف: electronic resource

    Relation: https://www.mdpi.com/2075-4418/12/7/1740; https://doaj.org/toc/2075-4418

    URL الوصول: https://doaj.org/article/683bdd4ed2e2407987165083b0d972a6

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer

    المؤلفون: Tsvetalina Tankova, Elżbieta Senkus, Maria Beloyartseva, Simona Borštnar, Doina Catrinoiu, Mona Frolova, Alinta Hegmane, Andrej Janež, Mladen Krnić, Zoltan Lengyel, Yiola Marcou, Laura Mazilu, Bela Mrinakova, Ruth Percik, Katarina Petrakova, Gábor Rubovszky, Margarita Tokar, Eduard Vrdoljak

    المصدر: Cancers, Vol 14, Iss 7, p 1598 (2022)

    مصطلحات موضوعية: adverse effect, alpelisib, hyperglycemia, PIK3CA-mutated metastatic breast cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://www.mdpi.com/2072-6694/14/7/1598; https://doaj.org/toc/2072-6694

    URL الوصول: https://doaj.org/article/c461356e094d48edbca0f96a5f137e62

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence

    المؤلفون: Milos Holanek, Iveta Selingerova, Ondrej Bilek, Tomas Kazda, Pavel Fabian, Lenka Foretova, Maria Zvarikova, Radka Obermannova, Ivana Kolouskova, Oldrich Coufal, Katarina Petrakova, Marek Svoboda, Alexandr Poprach

    المصدر: Cancers, Vol 13, Iss 7, p 1586 (2021)

    مصطلحات موضوعية: triple-negative breast cancer, neoadjuvant chemotherapy, early clinical response, pathological complete response, brca mutation, platinum salts, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://www.mdpi.com/2072-6694/13/7/1586; https://doaj.org/toc/2072-6694

    URL الوصول: https://doaj.org/article/705e0daa58fc46d2bc23b87a1e6fe6d9

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  4. 4
    nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HER2– metastatic breast cancer

    المؤلفون: Erika Hamilton, Javier Cortes, Ozgur Ozyilkan, Shin-Cheh Chen, Katarina Petrakova, Aleksey Manikhas, Guy Jerusalem, Roberto Hegg, Jens Huober, Wei Zhang, Yanyun Chen, Miguel Martin

    المصدر: Breast Cancer Research and Treatment. 195:55-64

    مصطلحات موضوعية: Tamoxifen, Cancer Research, Oncology, Antineoplastic Combined Chemotherapy Protocols, Aminopyridines, Humans, Benzimidazoles, Breast Neoplasms, Female, Progression-Free Survival

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a609ab7b50703563d92e648e5303db6
    https://doi.org/10.1007/s10549-022-06662-9

    Find this article in full text from ProQuest
    أضف إلى المفضلة
  5. 5
    Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer

    المؤلفون: Gabriel N. Hortobagyi, Salomon M. Stemmer, Howard A. Burris, Yoon-Sim Yap, Gabe S. Sonke, Lowell Hart, Mario Campone, Katarina Petrakova, Eric P. Winer, Wolfgang Janni, Pierfranco Conte, David A. Cameron, Fabrice André, Carlos L. Arteaga, Juan P. Zarate, Arunava Chakravartty, Tetiana Taran, Fabienne Le Gac, Paolo Serra, Joyce O’Shaughnessy

    المصدر: Hortobagyi, G N, Stemmer, S M, A. Burris, H, Sim Yap, Y, Sonke, G S, Hart, L, Campone, M, Petrakova, K, P. Winer, E, Janni, W, Conte, P, Cameron, D A, André, F, L Arteaga, C, Pablo Zarate, J, Chakravartty, A, Taran, T, Le Gac, F, Serra, P & O'Shaughnessy, J 2022, ' Overall Survival With Ribociclib Plus Letrozole in Advanced Breast Cancer ', New England Journal of Medicine . https://doi.org/10.1056/NEJMoa2114663

    مصطلحات موضوعية: Neutropenia, Receptor, ErbB-2, Aminopyridines, Breast Neoplasms, General Medicine, Middle Aged, Survival Analysis, Intention to Treat Analysis, Receptors, Estrogen, Purines, Antineoplastic Combined Chemotherapy Protocols, Letrozole, Humans, Female, Neoplasm Grading, Aged

    وصف الملف: application/pdf

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d6234684ca6ac2797fd74c653e1e73f
    https://doi.org/10.1056/nejmoa2114663

    Find this article in full text from ProQuest
    أضف إلى المفضلة
  6. 6
    Abstract P1-17-11: Updated data from AMEERA-1: Phase 1/2 study of amcenestrant (SAR439859), an oral selective estrogen receptor (ER) degrader (SERD), combined with palbociclib in postmenopausal women with ER+/HER2- advanced breast cancer

    المؤلفون: Sarat Chandarlapaty, Hannah M Linden, Patrick Neven, Katarina Petrakova, Aditya Bardia, Peter Kabos, Sofia Braga, Valentina Boni, Alice Gosselin, Marina Celanovic, Patrick Cohen, Gautier Paux, Vasiliki Pelekanou, Nils Ternès, Joon Sang Lee, Mario Campone

    المصدر: Cancer Research. 82:P1-17

    مصطلحات موضوعية: Cancer Research, Oncology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::56bb22f07ff1fc1e8b6810d66bc7f5a0
    https://doi.org/10.1158/1538-7445.sabcs21-p1-17-11

    أضف إلى المفضلة
  7. 7
    Abstract OT2-11-04: Ameera-1 Arm 5: Phase 1/2 study of amcenestrant (SAR439859), an oral selective estrogen receptor (ER) degrader (SERD), with abemaciclib in postmenopausal women with ER+/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer

    المؤلفون: Mario Campone, Sarat Chandarlapaty, Aditya Bardia, Patrick Neven, Katarina Petrakova, Peter Kabos, Valentina Boni, Sofia Braga, Marina Celanovic, Patrick Cohen, Alice Gosselin, Sylvaine Cartot-Cotton, Vasiliki Pelekanou, Hannah Linden

    المصدر: Cancer Research. 82:OT2-11

    مصطلحات موضوعية: Cancer Research, Oncology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bd5f79712d959b11b6cd02e51932107a
    https://doi.org/10.1158/1538-7445.sabcs21-ot2-11-04

    أضف إلى المفضلة
  8. 8
    Abstract OT2-11-02: Ameera-1 Arm 4: Phase 1/2 study of amcenestrant (SAR439859), an oral selective estrogen receptor (ER) degrader (SERD), with everolimus in postmenopausal women with ER+/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer

    المؤلفون: Mario Campone, Patrick Neven, Katarina Petrakova, Sofia Braga, Marina Celanovic, Patrick Cohen, Alice Gosselin, Sylvaine Cartot-Cotton, Vasiliki Pelekanou, Valentina Boni

    المصدر: Cancer Research. 82:OT2-11

    مصطلحات موضوعية: Cancer Research, Oncology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::908471b032c1be4f0bd40143f6db64a9
    https://doi.org/10.1158/1538-7445.sabcs21-ot2-11-02

    أضف إلى المفضلة
  9. 9
    Abstract P1-18-11: Analysis of first-line (1L) patients (pts) with de novo disease vs late relapse and all pts with vs without prior chemotherapy (CT) in the MONALEESA-3 (ML-3) trial

    المؤلفون: Michelino De Laurentiis, Matteo Lambertini, Stephen Chia, Hope S Rugo, Katarina Petrakova, Cristian Villanueva, Sara Hurvitz, J. Thaddeus Beck, Agnes Lteif, Sina Haftchenary, Uday Deore, Jiwen Wu, Nagi El-Saghir

    المصدر: Cancer Research. 82:P1-18

    مصطلحات موضوعية: Cancer Research, Oncology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::eb62fe36c399b79fd166cfdf9c73a00d
    https://doi.org/10.1158/1538-7445.sabcs21-p1-18-11

    أضف إلى المفضلة
  10. 10
    Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial

    المؤلفون: A.M. Brunt, Elizabeth A. Mittendorf, Michelle E. Melisko, Igor Bondarenko, Grybach Sergii, Julie A. Price Hiller, George E. Peoples, Biao Lu, Katarina Petrakova

    المصدر: Clinical Cancer Research. 25:4248-4254

    مصطلحات موضوعية: Adult, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Erythema, Receptor, ErbB-2, medicine.medical_treatment, Breast Neoplasms, Placebo, Cancer Vaccines, Asymptomatic, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Double-Blind Method, Internal medicine, medicine, Humans, Adverse effect, Aged, business.industry, Middle Aged, Prognosis, medicine.disease, Interim analysis, Peptide Fragments, Survival Rate, Clinical trial, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, Patient Safety, Neoplasm Recurrence, Local, medicine.symptom, business, Adjuvant

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::889cb57b9a37fd221c6237d5ce98ac89
    https://doi.org/10.1158/1078-0432.ccr-18-2867

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء